FI974447A - Semikarbatsonit, joilla on keskushermostoaktiivisuutta, ja niitä sisältävät farmaseuttiset valmisteet - Google Patents

Semikarbatsonit, joilla on keskushermostoaktiivisuutta, ja niitä sisältävät farmaseuttiset valmisteet Download PDF

Info

Publication number
FI974447A
FI974447A FI974447A FI974447A FI974447A FI 974447 A FI974447 A FI 974447A FI 974447 A FI974447 A FI 974447A FI 974447 A FI974447 A FI 974447A FI 974447 A FI974447 A FI 974447A
Authority
FI
Finland
Prior art keywords
nervous system
central nervous
semicarbazones
pharmaceutical preparations
preparations containing
Prior art date
Application number
FI974447A
Other languages
English (en)
Swedish (sv)
Other versions
FI974447A0 (fi
Inventor
Jonathan Richard Dimmock
Ramanan Narayan Puthucode
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Publication of FI974447A0 publication Critical patent/FI974447A0/fi
Publication of FI974447A publication Critical patent/FI974447A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/06—Compounds containing any of the groups, e.g. semicarbazides
    • C07C281/08—Compounds containing any of the groups, e.g. semicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones
    • C07C281/14—Compounds containing any of the groups, e.g. semicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones the carbon atom being further bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
FI974447A 1995-06-07 1997-12-05 Semikarbatsonit, joilla on keskushermostoaktiivisuutta, ja niitä sisältävät farmaseuttiset valmisteet FI974447A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/475,313 US5741818A (en) 1995-06-07 1995-06-07 Semicarbazones having CNS activity and pharmaceutical preparations containing same
PCT/CA1996/000380 WO1996040628A1 (en) 1995-06-07 1996-06-07 Semicarbazones having cns activity and pharmaceutical preparations containing same

Publications (2)

Publication Number Publication Date
FI974447A0 FI974447A0 (fi) 1997-12-05
FI974447A true FI974447A (fi) 1997-12-05

Family

ID=23887035

Family Applications (1)

Application Number Title Priority Date Filing Date
FI974447A FI974447A (fi) 1995-06-07 1997-12-05 Semikarbatsonit, joilla on keskushermostoaktiivisuutta, ja niitä sisältävät farmaseuttiset valmisteet

Country Status (24)

Country Link
US (2) US5741818A (fi)
EP (1) EP0836591B1 (fi)
JP (1) JPH11506109A (fi)
KR (1) KR19990022408A (fi)
CN (1) CN1062263C (fi)
AT (1) ATE206110T1 (fi)
AU (1) AU715897B2 (fi)
BR (1) BR9609408A (fi)
CA (1) CA2223935A1 (fi)
CZ (1) CZ387497A3 (fi)
DE (1) DE69615558T2 (fi)
DK (1) DK0836591T3 (fi)
ES (1) ES2164889T3 (fi)
FI (1) FI974447A (fi)
GE (1) GEP20012414B (fi)
HU (1) HUP9802637A3 (fi)
IL (1) IL122350A0 (fi)
NO (1) NO310655B1 (fi)
NZ (1) NZ309707A (fi)
PL (1) PL184048B1 (fi)
PT (1) PT836591E (fi)
RU (1) RU2174115C2 (fi)
UA (1) UA62915C2 (fi)
WO (1) WO1996040628A1 (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741818A (en) 1995-06-07 1998-04-21 University Of Saskatchewan Semicarbazones having CNS activity and pharmaceutical preparations containing same
EP1568690A1 (en) * 1997-04-22 2005-08-31 Euro-Celtique S.A. The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers
KR20010020201A (ko) 1997-04-22 2001-03-15 코센시스 인크 탄소고리 및 헤테로고리 치환된 세미카르바존 및 티오세미카르바존과 그들의 사용 방법
AU749214C (en) 1997-11-21 2006-03-30 Purdue Neuroscience Company Substituted 2-aminoacetamides and the use thereof
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
EP1058550A4 (en) * 1998-02-04 2002-12-18 Euro Celtique Sa SUBSTITUTED SEMICARBAZIDES AND THEIR USE
US6281211B1 (en) 1999-02-04 2001-08-28 Euro-Celtique S.A. Substituted semicarbazides and the use thereof
EP2266960B1 (en) 1999-03-26 2014-01-22 Euro-Celtique S.A. Aryl-substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles as anticonvulsants
WO2000061188A1 (en) * 1999-04-09 2000-10-19 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
US8771740B2 (en) 1999-12-20 2014-07-08 Nicholas J. Kerkhof Process for producing nanoparticles by spray drying
AU778931B2 (en) 1999-12-20 2004-12-23 Nicholas J. Kerkhof Process for producing nanometer particles by fluid bed spray-drying
AR029489A1 (es) 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
MXPA02009279A (es) * 2000-03-24 2004-09-10 Euro Celtique Sa Pirazoles, triazoles y tetrazoles sustituidos con arilo como bloqueadores del canal de sodio.
GB0025208D0 (en) 2000-10-13 2000-11-29 Euro Celtique Sa Delayed release pharmaceutical formulations
WO2002089745A2 (en) 2001-05-10 2002-11-14 Cytovia, Inc. Substituted n'-(arylcarbonyl)-benzhydrazides, n'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof
EP1399159A4 (en) * 2001-06-01 2007-02-14 Cytovia Inc 4-SUBSTITUTE-1- (ARYLMETHYLIDENE) THIOSEMICARBAZIDE, 4-SUBSTITUTE-1- (ARYLCARBONYL) THIOSEMICARBAZIDE AND ANALOGUES AS ACTIVATORS OF APOPTOSIS CAPSASES AND TRIGS, AND USE THEREOF
WO2003006426A1 (en) * 2001-07-13 2003-01-23 Axxima Pharmaceuticals Ag Aromatic guanylhydrazones as effective compounds against neurodiseases
WO2003020273A2 (en) 2001-09-03 2003-03-13 Newron Pharmaceuticals Spa Pharmaceutical composition comprising gabapentin or an analogue thereof and an $g(a)-aminoamide and its analgesic use
AR037233A1 (es) 2001-09-07 2004-11-03 Euro Celtique Sa Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
AR036873A1 (es) 2001-09-07 2004-10-13 Euro Celtique Sa Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
CA2484702A1 (en) * 2002-05-16 2003-11-27 Cytovia, Inc. Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
AU2003241482A1 (en) * 2002-05-16 2003-12-02 Cytovia, Inc. Substituted 4h-chromenes, 2h-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof
EP1438956A1 (en) * 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents
NZ553970A (en) * 2004-09-10 2010-01-29 Newron Pharm Spa Use of (halobenzyloxy)benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators
JP4827986B2 (ja) * 2007-06-08 2011-11-30 マンカインド コーポレ−ション ＩＲＥ−１αインヒビター
US9630275B2 (en) * 2008-12-10 2017-04-25 Boston Scientific Limited Methods and designs for forming joints between metallic members
CN104402771B (zh) * 2014-11-26 2016-09-28 玉林师范学院 对羟基苯甲醛缩氨基脲的合成及在防治植物病害中的应用
CN104974053B (zh) * 2015-06-24 2017-04-26 天津久日新材料股份有限公司 一种新的氨基酮类光引发剂及在uv‑led光固化体系的应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE667022A (fi)
US3255241A (en) 1961-01-19 1966-06-07 Merck & Co Inc (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
NL273765A (fi) 1961-01-19
BE622079A (fi) 1961-09-11
NL300456A (fi) 1962-11-13
US3251064A (en) 1962-11-13 1966-05-10 Everett M Schultz beta-aminoacylphenoxy-and beta-aminoacylphenylmercapto-derivatives of monocarboxylicacids
BE643709A (fi) * 1963-02-12 1900-01-01
DE1288086B (fi) * 1963-12-26 1969-01-30
US3304323A (en) * 1964-03-20 1967-02-14 Upjohn Co Oxygenated dicycloalkyl sulfones
US3392171A (en) * 1964-03-20 1968-07-09 Upjohn Co 4-morpholino-4'-hydroxy bicyclohexyls
US3303214A (en) * 1964-05-13 1967-02-07 Wallace & Tiernan Inc Nitrososemicarbazides
GB1164608A (en) * 1966-08-23 1969-09-17 May & Baker Ltd Semicarbazone and Thiosemicarbazone Quaternary Salts
US3712914A (en) * 1970-05-14 1973-01-23 Stauffer Chemical Co Arylidene semicarbizides
DE2420618C2 (de) * 1974-04-27 1982-09-16 C.H. Boehringer Sohn, 6507 Ingelheim Aminoalkylanilide, Verfahren zu ihrer Herstellung sowie pharmazeutische Zubereitungen, die diese Aminoalkylanilide enthalten
US4394514A (en) * 1981-04-30 1983-07-19 Smithkline Beckman Corporation Processes for preparing 4-substituted indoles
US5266585A (en) 1981-05-12 1993-11-30 Ciba-Geigy Corporation Arylphenyl ether derivatives, compositions containing these compounds and use thereof
FI77458C (fi) * 1981-05-12 1989-03-10 Ciba Geigy Ag Nya mikrobicida arylfenyleterderivat, foerfarande foer deras framstaellning och deras anvaendning.
US4454337A (en) * 1981-06-29 1984-06-12 Smithkline Beckman Corporation Semicarbazide intermediates for preparing 4-substituted indoles
US5665673A (en) 1988-12-29 1997-09-09 Anderson; Richard J. Potentiating herbicidal compositions
IL94466A (en) 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
WO1994006758A1 (en) * 1992-09-21 1994-03-31 University Of Saskatchewan Aryl semicarbazone anticonvulsants
WO1995031448A1 (en) 1994-05-17 1995-11-23 Dowelanco N-(5-isothiazolyl)amide pesticides
US5741818A (en) 1995-06-07 1998-04-21 University Of Saskatchewan Semicarbazones having CNS activity and pharmaceutical preparations containing same
TR199800767T2 (xx) 1995-10-30 1998-07-21 Smithkline Beecham Corporation Proteaz engelleyicileri.

Also Published As

Publication number Publication date
WO1996040628A1 (en) 1996-12-19
DE69615558T2 (de) 2002-07-11
ES2164889T3 (es) 2002-03-01
CN1062263C (zh) 2001-02-21
BR9609408A (pt) 1999-07-27
DK0836591T3 (da) 2001-11-26
FI974447A0 (fi) 1997-12-05
ATE206110T1 (de) 2001-10-15
JPH11506109A (ja) 1999-06-02
CA2223935A1 (en) 1996-12-19
AU5993896A (en) 1996-12-30
PL323666A1 (en) 1998-04-14
CN1190388A (zh) 1998-08-12
GEP20012414B (en) 2001-04-25
HUP9802637A3 (en) 2000-09-28
CZ387497A3 (cs) 1998-07-15
USRE38425E1 (en) 2004-02-10
RU2174115C2 (ru) 2001-09-27
NO310655B1 (no) 2001-08-06
EP0836591A1 (en) 1998-04-22
DE69615558D1 (de) 2001-10-31
KR19990022408A (ko) 1999-03-25
NO975663L (no) 1998-02-09
UA62915C2 (en) 2004-01-15
US5741818A (en) 1998-04-21
PL184048B1 (pl) 2002-08-30
EP0836591B1 (en) 2001-09-26
HUP9802637A2 (hu) 1999-02-01
NZ309707A (en) 1998-11-25
IL122350A0 (en) 1998-04-05
AU715897B2 (en) 2000-02-10
NO975663D0 (no) 1997-12-05
PT836591E (pt) 2002-03-28

Similar Documents

Publication Publication Date Title
FI974447A (fi) Semikarbatsonit, joilla on keskushermostoaktiivisuutta, ja niitä sisältävät farmaseuttiset valmisteet
DE69528273D1 (de) 1,2-substituierte imidazolylverbindungen zur behandlung von entzündungen
FI931888A0 (fi) Kramploesande cykliska fruktopyranossulfiter -och sulfater
ATE176664T1 (de) 2-propylvaleriansäure und 2-propylvalerian- säureamid-derivate und deren verwendung als antikonvulsive mittel
ATE209186T1 (de) Überbrückte azabicyclische derivate als substanz p antagonisten
AR038431A2 (es) Derivados 2-desoxo-15-alquilo de marcfortina
NO981269L (no) Forbindelser som forsterker virkningen av retinoider
TR199800924T2 (xx) Quinoline t�revleri.
DE69113155D1 (de) 17-beta-substituierte-4-aza-5-alpha-androstan-3-one-derivate und verfahren zu ihrer herstellung.
DE69615682D1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h-benzo[b][1,5]-diazepin-3-yl)-acetamide
ATE122042T1 (de) Pyrazoloisoquinoline-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DE69808099D1 (de) Substituierte 6-alkylphenanthridine
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
ATE164592T1 (de) Antiretrovirale acyl-verbindungen
ATE150450T1 (de) 5-oxo-dibenzo(a,d&gt;cyclohepta-1,4-diene und ihre verwendung als retrovirale mittel
DE69402935D1 (de) Substituierte arylalkylaminobenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel
ATE274905T1 (de) 4,5-dihydroxy-2-cyclopentene-1-on für die behandlung von rheumatismus, entzündungen und autoimmunerkrankungen
ES2123728T3 (es) Derivados de pirrolo-pirazina de actividad 5-ht3.
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
AU579416B2 (en) 3-Amino-2,3-dihydro-1-benzoxepine-compounds and methods for their preparation and pharmaceutical preparations containing these compounds
ES2173634T3 (es) Compuestos heterociclicos que presentan actividad inhibidora de mmp y tnf.
TH16651A (fi)
YU49004B (sh) LANOSTA-7,9-DIEN-3Гџ, 32-DIOL I POSTUPAK ZA NJEGOVO DOBIJANJE